BTG Plc – Strategy, SWOT and Corporate Finance Report
- Pages: 62
- Published: September 2018
- Report Code: MLPH66560FSA
BTG Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.
BTG plc (BTG) develops, manufactures and sells medicines for acute care, cancer and vascular diseases. The company develops specialty drugs including antidotes for snake envenomation and toxicity related to medicines used for heart conditions and cancer; interventional vascular products for treating patients with severe blood clots and varicose veins; and interventional cancer products for treating patients with liver tumors and emphysema. The company develops products and acquires or in-licenses from other companies. BTG markets its products either directly or through distribution agreements. The company operates along with its subsidiaries in the US, Europe and Asia. BTG is headquartered in London, England, the UK.
Scope
Detailed information on BTG Plc required for business and competitor intelligence needs
A study of the major internal and external factors affecting BTG Plc in the form of a SWOT analysis
An in-depth view of the business model of BTG Plc including a breakdown and examination of key business segments
News about BTG Plc, such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of BTG Plc and the factors that influence its strategies.Track strategic initiatives of the company and latest corporate news and actions.
Assess BTG Plc as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on BTG Plcs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Transgene SA
Sirtex Medical Ltd
Merit Medical Systems Inc
Immupharma Plc
F. Hoffmann-La Roche Ltd
CeloNova BioSciences Inc
Baxter International Inc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.